925.4500 12.10 (1.32%)
NSE May 06, 2025 13:50 PM
Volume: 120.4K
 

925.45
1.32%
Prabhudas Lilladhar
and 3) increased employee cost at 16% of sales (v/s 11% YoY and 13% QoQ). EBIT margin for diagnostic segment was 9% v/s 42% YoY. its profitability because of 1) lower gross margin at 53% (v/s 72% YoY) due to We remain negative on entire diagnostic chain due to possible structural...
ICICI Securities Limited increased Buy price target of Thyrocare Technologies Ltd. to 1000.0 on 24 Apr, 2025.
More from Thyrocare Technologies Ltd.
Recommended